Innovation Ignites, Buybacks Surge, and Macy’s Delivers a Retail Revival

September 3, 2025

DENVER, Colo., Sep 03, 2025 (247marketnews.com)- From award-winning graphite tech to billion-dollar amphitheaters, here’s what’s powering the morning narrative:

Solidion Technology (NASDAQ:STI) is today’s most active listing after its E-GRIMS technology, developed in partnership with Oak Ridge National Laboratory, earned a coveted 2025 R&D 100 Award. The electrochemical graphite process enables energy-efficient, scalable, and eco-friendly graphite production, vital for next-gen lithium-ion batteries. CEO Jaymes Winters said the award underscores the company’s mission to “bring greener and more sustainable graphitization methods to global markets.”

Solidion is now moving to pilot and commercial deployment, inviting partners to join its sustainable energy push. The award win adds momentum to a stock already drawing increased investor attention.

SINTX Technologies (NASDAQ:SINT) soared after revealing peer-reviewed research confirming that its silicon nitride material has broad-spectrum antiviral activity, including effectiveness against SARS-CoV-2 and MERS-CoV. The study, conducted with Virginia Tech, positions silicon nitride as a powerful platform for infection-control applications, from hospital textiles to HEPA filters.

CTO Dr. Ryan Bock called the findings “transformative,” noting the material’s ability to inactivate dangerous viruses in minutes, unlocking opportunities in multi-billion-dollar infection prevention markets.

VENU (NYSE:VENU) completed a $34.5 million public offering, including the full exercise of the underwriter’s option, bolstering development of its 20,000-seat Sunset Amphitheaters in Texas and Oklahoma. Proceeds will also support working capital and strategic expansion, targeting underserved U.S. markets with a blend of premium live entertainment and upscale hospitality.

The raise comes amid increased institutional interest, including an 861,911-share stake by Vanguard Group. VENU is aiming for $2 billion in ticket sales by 2030, scaling a $5 billion development pipeline with iconic destination venues.

Macy’s (NYSE:M) shares surged over 14% premarket after the retailer beat Q2 estimates and raised full-year guidance. The company reported $4.8 billion in net sales and $0.41 adjusted EPS, easily topping expectations. Comparable sales rose across all banners, with Bloomingdale’s up 5.7% on an O+L+M basis and Bluemercury logging its 18th consecutive quarter of growth.

CEO Tony Spring credited the performance to a “multi-brand, multi-category, omni-channel” approach and highlighted progress in the Bold New Chapter transformation plan.

LightPath Technologies (NASDAQ:LPTH) secured an $18.2 million order from a global technology leader for infrared camera systems to be delivered in 2026, with expectations of an additional $22 million tranche in 2027. CEO Sam Rubin noted that geopolitical demand and China’s restrictions on Germanium have boosted interest in LightPath’s BlackDiamond glass optics as a secure alternative.

The deal marks a milestone in LightPath’s pivot to vertically integrated solutions, with up to $40 million in total potential value.

TG Therapeutics (NASDAQ:TGTX) completed its $100 million share repurchase program, buying back 3.5 million shares at an average of $28.55 per share. The Board has now authorized a new $100 million buyback, signaling confidence in the company’s valuation and the long-term potential of BRIUMVI, its approved treatment for MS and other autoimmune diseases.

CEO Michael Weiss said August’s $78 million repurchase was executed at “highly attractive prices,” adding, “Current market prices do not adequately reflect the multibillion-dollar potential of BRIUMVI.”

Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (STI, SINT, VENU, LPTH, TGTX, M)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.